Cyclotek is currently engaged to manufacture PET tracers for clinical trials relating to:
Cyclotek has the capacity to manufacture PET radiopharmaceuticals for research and clinical trials under contract; in particular, radiopharmaceuticals for use in Phase II/III trials manufactured under GMP.
Cyclotek operates dedicated production and QC facilities for investigational products. The capacity exists to:
On completion of trials, Cyclotek can offer contract or licensed manufacture of commercial product.